Japan’s MHLW Receives sNDA for T-DXd Combo in Frontline HER2+ Breast Cancer
Refining Management of Immune-Checkpoint Inhibitor Toxicities in Melanoma: A review of strategies and management practices for melanoma cases using immune-checkpoint inhibitors, exploring impacts on patient outcomes and future perspectives.
FDA Grants Fast Track Designation to SRN-101 for Recurrent High-Grade Glioma: FDA’s recent fast-track designation for SRN-101, a potential treatment for recurrent high-grade glioma. Regulatory and clinical implications are discussed.
Novel Small Molecule Shows Early Activity in Pretreated Multiple Myeloma: An innovative small molecule exhibiting promising early activity in treating multiple myeloma cases.
Comparing Quality of Life Outcomes with Protons vs Photons in OPSCC: A comparison of quality of life outcomes between proton and photon therapies in Oropharyngeal Squamous Cell Carcinoma (OPSCC).
3 Things You Should Know About PSMA-Directed Imaging and Radioligand Therapy in Prostate Cancer: Essential insights on PSMA-directed imaging and radioligand therapy in treating prostate cancer.
